bf/NASDAQ:SLRN_icon.jpeg

COM:ACELYRIN

Acelyrin, Inc.

  • Stock

Last Close

4.72

20/11 21:00

Market Cap

508.01M

Beta: -

Volume Today

338.14K

Avg: -

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, P...Show More

investor of